The arrival of Retatrutide ZPHC, at a strength of 120mg, is creating considerable buzz within the weight loss community. This novel dual GIP and GLP-1 receptor medication suggests to deliver notable improvements in weight shedding compared to previous therapies. Early patient data have demonstrat